Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies
Juanxia Meng(Nankai University), Mingfeng Zhao(Nankai University), Hairong Lyu(University of Bristol), Haibo Zhu(Tianjin First Center Hospital), Zhao Wang(Tianjin First Center Hospital), Xiaoyuan He(Nankai University), Xia Xiao(Jilin University), Yedi Pu(Tianjin First Center Hospital), Xue Bai(Southwest Medical University)
Cited by 2
Related Papers
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
|Cell Death and Disease|2013|129
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
|Frontiers in Oncology|2020|82
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome
|Cancer Science|2021|73
Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression
|Journal of Biological Chemistry|2019|52